Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Methyldopa Tablets 250mg

Research Leaders

5 sponsors active, led by University of Washington

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Unknown2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Methyldopa Tablets 250mg1
  • Methyldopa Tablets 250mg Foot Reflexology1

Active Sponsors

  • University of Washington1
  • University of Cape Town1
  • Cairo University1
  • Second Affiliated Hospital of Wenzhou Medical University1
  • Zekai Tahir Burak Women's Health Research and Education Hospital1

Top Investigators

  • Second Affiliated Hospital of Wenzhou Medical University

  • Zekai Tahir Burak Women's Health Research and Education Hospital

Related Conditions

  • Severe Preeclampsia2
  • Gestational Hypertension1

Activity Timeline